{"gene":"ARF3","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1990,"finding":"ARF protein is functionally and physically associated with the Golgi apparatus, localizing to the cytosolic surface of predominantly cis-Golgi membranes, and is required for intracellular protein transport to or within the Golgi apparatus, as demonstrated by phenotypic analysis of yeast arf1 null mutants (defective secretory pathway, partial glycosylation of invertase) and immunofluorescence/immunoelectron microscopy in mammalian cells.","method":"Yeast genetics (null mutation), immunofluorescence, immunoelectron microscopy","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal genetic and direct localization evidence, foundational study with 342 citations","pmids":["2105501"],"is_preprint":false},{"year":1993,"finding":"ARF proteins are the only cytoplasmic proteins required, together with coatomer, for the assembly and budding of COP-coated vesicles from Golgi membranes, demonstrating a direct role in coated vesicle formation.","method":"In vitro reconstitution of vesicle budding from Golgi membranes using purified cytosolic fractions","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstitution assay with purified components, highly cited foundational study","pmids":["8355790"],"is_preprint":false},{"year":1993,"finding":"Two distinct populations of ARF exist on Golgi membranes: a liposome-sensitive pool that associates with the lipid bilayer upon GTP binding, and a saturable liposome-resistant pool that stably associates with a Golgi membrane protein component, suggesting ARF activation by a guanine nucleotide-exchange protein leads to myristoylated ARF-GTP membrane association followed by interaction with a target protein.","method":"Phosphatidylcholine liposome extraction of Golgi membranes, ARF binding assays with GTPγS","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with Golgi membranes and defined lipid competition, replicated across conditions","pmids":["8491770"],"is_preprint":false},{"year":1996,"finding":"A brefeldin A (BFA)-inhibited guanine nucleotide exchange protein (GEP) for ARF1 and ARF3 was purified from bovine brain cytosol; it is a ~200 kDa protein forming a ~670 kDa complex, and contains a Sec7-like domain (47% identity to yeast Sec7 over 51 amino acids), consistent with it being a mammalian Sec7 counterpart catalyzing ARF GDP-to-GTP exchange.","method":"Protein purification (DEAE-Sephacel, hydroxylapatite, Mono Q, Superose 6), SDS/PAGE, tryptic peptide sequencing, electroelution/renaturation activity assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — biochemical purification with activity reconstitution and peptide sequencing identification","pmids":["8917509"],"is_preprint":false},{"year":2000,"finding":"Three residues of human ARF3 (F51, W66, Y81) form a hydrophobic pocket in the GDP-bound inactive state; mutations disrupting this pocket increased the rate of GDP dissociation and association without equivalently affecting GTPγS binding, and several mutants were selectively defective in binding different ARF effectors, establishing that this pocket regulates GDP release, conformational changes promoting GTP binding, and effector recognition.","method":"Site-directed mutagenesis of ARF3, GDP/GTP exchange rate assays, yeast two-hybrid effector binding assays","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with in vitro nucleotide exchange assays and effector binding tests","pmids":["11150519"],"is_preprint":false},{"year":2000,"finding":"A family of three ARF effector proteins (GGA1, GGA2, GGA3) were identified that interact preferentially with the GTP-bound (activated) form of ARF3; they localize to the trans-Golgi network (TGN) in an ARF- and BFA-sensitive manner, and overexpression alters distribution of TGN markers (TGN38, mannose 6-phosphate receptors), establishing GGAs as ARF3 effectors regulating membrane traffic through the TGN.","method":"Yeast two-hybrid screen with ARF3 as bait, recombinant protein binding assays, indirect immunofluorescence, BFA sensitivity assays, overexpression phenotypic analysis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1-2 — two-hybrid plus direct protein binding plus localization plus gain-of-function phenotype, multiple orthogonal methods","pmids":["10749927"],"is_preprint":false},{"year":2010,"finding":"In vivo, Arf3 (human class I ARF) localizes selectively to TGN membranes in a temperature-sensitive and BIG-family GEF-dependent manner distinct from Arf1; BIG1/BIG2 knockdown redistributes Arf3 but not Arf1 from Golgi membranes; shifting cells to 20°C selectively releases Arf3 from Golgi. Mutagenesis identified two pairs of residues at opposite ends of the protein responsible for TGN recruitment and temperature-dependent release. Phylogenetic analysis confirmed these four residues are absolutely conserved and unique to Arf3.","method":"siRNA knockdown, temperature-shift experiments, mutagenesis, fluorescence microscopy, phylogenetic analysis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (KD, temperature shift, mutagenesis) in single rigorous study","pmids":["20357002"],"is_preprint":false},{"year":2012,"finding":"Simultaneous depletion of ARF1 and ARF3 (but not either alone) induces tubulation of recycling endosomes positive for transferrin receptor, Rab4, and Rab11, and suppresses transferrin recycling from endosomes to the plasma membrane, without affecting Golgi integrity, early/late endosome function, or retrograde transport from endosomes to TGN. EGFP-tagged ARF1 and ARF3 localize to endosomal compartments containing endocytosed transferrin. ARF1 and ARF3 are thus redundantly required for recycling endosome integrity and transferrin recycling.","method":"siRNA double knockdown, EGFP localization, transferrin recycling assay, TGN38/CD4-furin retrograde transport assays, fluorescence microscopy","journal":"Cell structure and function","confidence":"High","confidence_rationale":"Tier 2 — clean double KO with multiple specific functional readouts and localization experiments","pmids":["22971977"],"is_preprint":false},{"year":2015,"finding":"Class I Arfs (Arf1 and Arf3) localize to the Flemming body during cytokinesis; double knockdown of Arf1 and Arf3 moderately increases multinucleate cells, and triple knockdown of Arf1, Arf3, and Arf6 leads to severe cytokinesis defects. EFA6, an Arf6 exchange factor, also activates Arf1 in cells, suggesting EFA6 activates multiple Arfs locally at the Flemming body to complete cytokinesis.","method":"siRNA knockdown (single, double, triple), fluorescence localization to Flemming body, multinucleate cell quantification","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — clean KD with specific cytokinesis phenotype, but Arf3-specific contribution partially confounded by redundancy with Arf1","pmids":["26330566"],"is_preprint":false},{"year":2020,"finding":"BIG1 (a BFA-inhibited GEF) controls macrophage pro-inflammatory responses through ARF3 activation; myeloid-specific BIG1 knockout reduces ARF3 activation, leading to decreased PI(4,5)P2 synthesis, impaired TIRAP recruitment to the plasma membrane, and inhibition of TLR4-MyD88 signaling, thereby reducing TNF-α, IL-6, IL-1β, and IL-12 production in response to LPS.","method":"Myeloid-specific conditional knockout mice, LPS/CLP sepsis models, ARF3 activation assay, PI(4,5)P2 measurement, TIRAP membrane recruitment assay, cytokine quantification","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo KO with multiple downstream mechanistic readouts, but ARF3 activation shown indirectly downstream of BIG1 KO","pmids":["32415087"],"is_preprint":false},{"year":2021,"finding":"De novo missense variants in human ARF3 (p.Asp67Val and p.Arg99Leu) cause neurodevelopmental disorder with brain abnormalities. p.Asp67Val acts as a loss-of-function variant showing dispersed cytosolic/Golgi localization similar to the dominant-negative p.Thr31Asn, and decreased GGA1 binding. p.Arg99Leu localizes normally to Golgi but shows increased GGA1 binding (gain-of-function). In vivo, p.Asp67Val transfection caused lethality in Drosophila, while p.Arg99Leu caused abnormal rough eye (gain-of-function phenotype), demonstrating ARF3 is essential for Golgi transport and nervous system development.","method":"In vitro subcellular localization assays, pull-down assays for GGA1 binding, Drosophila in vivo expression of mutants","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (localization, pull-down, in vivo fly models) across two variants","pmids":["34346499"],"is_preprint":false},{"year":2022,"finding":"De novo missense ARF3 variants affecting the guanine nucleotide binding pocket variably perturb protein stability and GTP/GDP binding, with functional consequences including disrupted Golgi morphology and impaired vesicle assembly and trafficking. Zebrafish modeling confirmed dominant behavior of mutants, with differential impacts on brain size (impaired neural precursor proliferation) and body plan formation via planar cell polarity-dependent cell movements.","method":"Cell-based Golgi morphology assays, GTP/GDP binding assays, vesicle trafficking assays, zebrafish disease modeling, in vivo neural precursor proliferation analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal biochemical and in vivo methods across several variants, independently replicating and expanding prior findings","pmids":["36369169"],"is_preprint":false},{"year":2023,"finding":"ARF3 GTPase controls the modality of collective invasion in prostate cancer cells, acting as a switch between leader cell-led chain invasion and collective sheet movement; this function is dependent on ARF3's association with and control of N-cadherin turnover. In vivo, ARF3 levels acted as a rheostat for metastasis from intraprostatic tumor transplants.","method":"3D functional genomic screen, ARF3 KD/KO, N-cadherin co-immunoprecipitation and turnover assays, in vivo intraprostatic transplant metastasis model","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — functional screen plus mechanistic follow-up with binding partner and in vivo validation, single lab study","pmids":["36880595"],"is_preprint":false},{"year":2025,"finding":"ARF3 knockdown inhibits influenza A virus (H3N2) replication in vitro and alleviates IAV-induced lung injury and pulmonary inflammation in vivo by attenuating NLRP3 inflammasome activation and reducing pro-inflammatory cytokines (TNF-α, IL-6, IL-1β).","method":"ARF3 knockdown in vitro (IAV replication assay), young mouse IAV pneumonia model, NLRP3 inflammasome activation assay, cytokine measurement","journal":"Virus genes","confidence":"Medium","confidence_rationale":"Tier 2 — KD with specific viral replication and inflammasome phenotype, but single lab, mechanism between ARF3 and NLRP3 not fully dissected","pmids":["40608252"],"is_preprint":false},{"year":2025,"finding":"ARF3 knockdown in AML cells interrupts cell cycle progression, promotes cell death, and inhibits leukemogenesis in vivo; mechanistically, ARF3 knockdown suppresses AML progression by inhibiting the PI3K/Akt signaling pathway.","method":"siRNA knockdown of ARF3 in AML cell lines, cell cycle and apoptosis assays, in vivo xenograft model, western blotting for PI3K/Akt pathway components","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — KO with in vivo validation and pathway measurement, but single lab and PI3K/Akt link is correlational","pmids":["39756487"],"is_preprint":false}],"current_model":"ARF3 is a small GTPase that cycles between GDP-bound (inactive) and GTP-bound (active) states regulated by BFA-sensitive Sec7-domain GEFs (including BIG1/BIG2); in its active GTP-bound form it recruits effectors such as GGA proteins to the trans-Golgi network to drive coated vesicle assembly and cargo sorting, localizes selectively to the TGN (distinct from the broader Golgi distribution of ARF1) in a BIG-GEF-dependent manner, and together with ARF1 redundantly maintains recycling endosome integrity and transferrin recycling to the plasma membrane; de novo gain- or loss-of-function mutations in its guanine nucleotide-binding pocket cause Golgi fragmentation, impaired vesicle trafficking, and a human neurodevelopmental Golgipathy; additionally, ARF3 controls macrophage inflammatory signaling via PI(4,5)P2 synthesis downstream of BIG1, regulates collective cancer cell invasion modality through N-cadherin turnover, participates in cytokinesis at the Flemming body, and modulates NLRP3 inflammasome-dependent inflammatory responses during viral infection."},"narrative":{"teleology":[{"year":1990,"claim":"Establishing that ARF proteins localize to the Golgi apparatus and are required for secretory transport answered the fundamental question of where and why ARFs act in the cell.","evidence":"Yeast arf1 null mutant secretion defects combined with immunofluorescence and immunoelectron microscopy of mammalian Golgi membranes","pmids":["2105501"],"confidence":"High","gaps":["ARF isoform-specific functions not distinguished","Mechanism of ARF membrane attachment unresolved"]},{"year":1993,"claim":"Reconstitution of COP-coated vesicle budding from purified ARF and coatomer defined the minimal machinery for Golgi vesicle formation and showed ARF is an essential coat-assembly factor, while parallel work revealed two distinct modes of ARF-membrane association (lipid-dependent and protein-dependent).","evidence":"In vitro reconstitution of vesicle budding from Golgi membranes with purified components; liposome extraction and GTPγS-dependent ARF binding assays","pmids":["8355790","8491770"],"confidence":"High","gaps":["Identity of the saturable Golgi membrane receptor for ARF unknown","ARF3-specific contribution versus ARF1 not resolved"]},{"year":1996,"claim":"Purification of a ~200 kDa BFA-sensitive guanine nucleotide exchange factor for ARF1/ARF3 containing a Sec7-like domain identified the upstream activator and explained how BFA blocks ARF-dependent vesicle trafficking.","evidence":"Biochemical purification from bovine brain cytosol with activity reconstitution and tryptic peptide sequencing","pmids":["8917509"],"confidence":"High","gaps":["Molecular identity of this GEF not fully cloned at this stage","Whether distinct GEFs preferentially activate ARF3 versus ARF1 unknown"]},{"year":2000,"claim":"Mutagenesis of a hydrophobic pocket in ARF3 (F51/W66/Y81) established how conformational changes couple GDP release to effector recognition, while identification of GGA1–3 as GTP-dependent ARF3 effectors at the TGN defined the downstream pathway for clathrin-mediated sorting.","evidence":"Site-directed mutagenesis with nucleotide exchange and effector binding assays; yeast two-hybrid screen with ARF3-GTP, pull-down, and BFA-sensitive TGN localization of GGAs","pmids":["11150519","10749927"],"confidence":"High","gaps":["Structural basis of GGA–ARF3 interface not determined","Whether all three GGAs are equally relevant in vivo unclear"]},{"year":2010,"claim":"Demonstrating that ARF3 localizes selectively to TGN membranes via BIG1/BIG2-dependent activation, distinct from the broader Golgi distribution of ARF1, resolved a long-standing question about isoform-specific compartmentalization and identified four conserved residues unique to ARF3 responsible for TGN targeting.","evidence":"siRNA knockdown of BIG1/BIG2, temperature-shift release experiments, and mutagenesis of ARF3-specific residues with fluorescence microscopy","pmids":["20357002"],"confidence":"High","gaps":["Identity of TGN receptor that recognizes ARF3-specific residues unknown","Functional consequence of selective TGN targeting versus redundancy with ARF1 incompletely tested"]},{"year":2012,"claim":"Double depletion of ARF1 and ARF3 revealed their redundant requirement for recycling endosome structural integrity and transferrin recycling, extending ARF3 function beyond the Golgi to endosomal compartments.","evidence":"siRNA double knockdown with transferrin recycling quantification, endosome tubulation assays, and EGFP-ARF localization to transferrin-positive endosomes","pmids":["22971977"],"confidence":"High","gaps":["GEFs and effectors mediating ARF3 function specifically at recycling endosomes not identified","Relative stoichiometric contributions of ARF1 versus ARF3 at endosomes unclear"]},{"year":2015,"claim":"Localization of ARF1/ARF3 to the Flemming body and cytokinesis defects upon their combined depletion extended ARF3 function to cell division, though ARF3's specific contribution is partially confounded by redundancy.","evidence":"siRNA single/double/triple knockdowns of Arf1, Arf3, and Arf6 with multinucleate cell quantification and Flemming body localization","pmids":["26330566"],"confidence":"Medium","gaps":["ARF3-specific role at the Flemming body not separable from ARF1","Downstream effectors at the Flemming body not identified","Single study without independent replication"]},{"year":2020,"claim":"Placing ARF3 downstream of BIG1 in macrophage TLR4 signaling—through PI(4,5)P₂ synthesis and TIRAP membrane recruitment—revealed an unexpected role for this trafficking GTPase in innate immune signal transduction.","evidence":"Myeloid-specific BIG1 conditional knockout mice with LPS/CLP sepsis models, ARF3 activation assays, PI(4,5)P₂ quantification, and TIRAP membrane recruitment","pmids":["32415087"],"confidence":"Medium","gaps":["ARF3 activation measured indirectly via BIG1 KO rather than direct ARF3 perturbation","How ARF3-GTP activates PI(4,5)P₂ synthesis enzymes mechanistically unresolved"]},{"year":2021,"claim":"Identification of de novo ARF3 missense mutations (p.Asp67Val, p.Arg99Leu) in patients with neurodevelopmental disorder established ARF3 as a human disease gene and demonstrated that gain- and loss-of-function variants in the nucleotide-binding pocket produce distinct cellular and in vivo phenotypes.","evidence":"Patient genotyping, subcellular localization, GGA1 pull-down assays, Drosophila in vivo expression of mutant ARF3","pmids":["34346499"],"confidence":"High","gaps":["Neurodevelopmental mechanism downstream of impaired Golgi trafficking not delineated","Limited patient cohort at initial report"]},{"year":2022,"claim":"Expanded variant characterization in zebrafish confirmed dominant behavior of disease-associated ARF3 mutations and linked differential GTP/GDP binding perturbations to distinct effects on brain size and planar cell polarity, providing the first vertebrate disease model.","evidence":"Cell-based Golgi morphology and vesicle trafficking assays, GTP/GDP binding measurements, zebrafish disease modeling with neural precursor proliferation analysis","pmids":["36369169"],"confidence":"High","gaps":["Specific cell types and developmental windows most sensitive to ARF3 dysfunction not defined","Whether therapeutic correction of GTPase cycle is feasible untested"]},{"year":2023,"claim":"A 3D functional genomic screen identified ARF3 as a controller of collective cancer invasion modality, acting through N-cadherin turnover to switch between chain and sheet migration, and revealed ARF3 levels modulate metastasis in vivo.","evidence":"3D screen, ARF3 KD/KO, N-cadherin co-immunoprecipitation and turnover, intraprostatic transplant metastasis model","pmids":["36880595"],"confidence":"Medium","gaps":["Whether ARF3 directly binds N-cadherin or acts through an intermediary not resolved","Generalizability beyond prostate cancer not tested","Single lab study"]},{"year":2025,"claim":"ARF3 knockdown attenuated NLRP3 inflammasome activation during influenza infection in vitro and in vivo, positioning ARF3 as a positive regulator of inflammasome-dependent pulmonary inflammation; separately, ARF3 depletion in AML cells arrested cell cycle and inhibited leukemogenesis correlating with PI3K/Akt pathway suppression.","evidence":"ARF3 KD with IAV replication and NLRP3 activation assays in mouse pneumonia model; ARF3 KD in AML cell lines with xenograft model and PI3K/Akt western blotting","pmids":["40608252","39756487"],"confidence":"Medium","gaps":["Mechanistic link between ARF3 GTPase activity and NLRP3 assembly not dissected","PI3K/Akt connection in AML is correlational—direct substrate or adaptor unknown","Neither finding independently replicated"]},{"year":null,"claim":"Key unresolved questions include: the identity of the TGN membrane receptor that selectively recognizes ARF3 over ARF1, the structural basis for effector selectivity among ARF3 disease variants, the precise mechanism by which ARF3-GTP activates PI(4,5)P₂ synthesis, and whether therapeutic modulation of the ARF3 GTPase cycle could rescue the associated Golgipathy.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of ARF3–effector complexes available","TGN-specific ARF3 receptor not molecularly identified","No therapeutic intervention studies"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[3,4,10,11]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,9,12]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,2,6,10,11]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[7]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[1,7]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,10]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[9]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,5,6,7,10,11]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[5,6,7]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[9,13]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,14]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[8,14]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[10,11]}],"complexes":[],"partners":["GGA1","GGA2","GGA3","BIG1","BIG2","ARF1","CDH2"],"other_free_text":[]},"mechanistic_narrative":"ARF3 is a class I ADP-ribosylation factor (small GTPase) that cycles between GDP-bound inactive and GTP-bound active states on endomembranes, functioning as a master regulator of vesicle coat assembly, cargo sorting, and membrane homeostasis at the trans-Golgi network, recycling endosomes, and the Flemming body during cytokinesis. In its GTP-bound form, ARF3 is recruited to TGN membranes in a BIG1/BIG2-dependent manner—distinct from the broader Golgi distribution of ARF1—where it engages effectors such as GGA1–3 to drive clathrin-coated vesicle formation and mannose 6-phosphate receptor trafficking [PMID:20357002, PMID:10749927]; together with ARF1 it redundantly maintains recycling endosome tubular architecture and transferrin recycling [PMID:22971977]. Beyond canonical trafficking, ARF3 controls macrophage TLR4 inflammatory signaling via BIG1-dependent PI(4,5)P₂ synthesis and TIRAP membrane recruitment [PMID:32415087], modulates NLRP3 inflammasome activation during influenza infection [PMID:40608252], and regulates collective cancer cell invasion through N-cadherin turnover [PMID:36880595]. De novo missense mutations in the ARF3 guanine-nucleotide-binding pocket cause a neurodevelopmental Golgipathy featuring brain malformations, with variants classified as gain- or loss-of-function based on effector binding and Golgi morphology effects validated in Drosophila and zebrafish models [PMID:34346499, PMID:36369169]."},"prefetch_data":{"uniprot":{"accession":"P61204","full_name":"ADP-ribosylation factor 3","aliases":[],"length_aa":181,"mass_kda":20.6,"function":"GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus","subcellular_location":"Golgi apparatus; Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/P61204/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARF3","classification":"Not Classified","n_dependent_lines":27,"n_total_lines":1208,"dependency_fraction":0.022350993377483443},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000134287","cell_line_id":"CID000654","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"golgi","grade":3},{"compartment":"nucleoplasm","grade":3},{"compartment":"vesicles","grade":3}],"interactors":[],"url":"https://opencell.sf.czbiohub.org/target/CID000654","total_profiled":1310},"omim":[{"mim_id":"605928","title":"ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 1; ARFIP1","url":"https://www.omim.org/entry/605928"},{"mim_id":"605926","title":"PROTEIN INTERACTING WITH C KINASE 1; PICK1","url":"https://www.omim.org/entry/605926"},{"mim_id":"604141","title":"ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; ARFGEF1","url":"https://www.omim.org/entry/604141"},{"mim_id":"601638","title":"ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 2; ARFIP2","url":"https://www.omim.org/entry/601638"},{"mim_id":"600732","title":"ADP-RIBOSYLATION FACTOR-LIKE GTPase 4D; ARL4D","url":"https://www.omim.org/entry/600732"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":271.2}],"url":"https://www.proteinatlas.org/search/ARF3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P61204","domains":[{"cath_id":"3.40.50.300","chopping":"73-178","consensus_level":"high","plddt":94.8799,"start":73,"end":178}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P61204","model_url":"https://alphafold.ebi.ac.uk/files/AF-P61204-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P61204-F1-predicted_aligned_error_v6.png","plddt_mean":86.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARF3","jax_strain_url":"https://www.jax.org/strain/search?query=ARF3"},"sequence":{"accession":"P61204","fasta_url":"https://rest.uniprot.org/uniprotkb/P61204.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P61204/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P61204"}},"corpus_meta":[{"pmid":"15980147","id":"PMC_15980147","title":"A database analysis method identifies an endogenous trans-acting short-interfering RNA that targets the Arabidopsis ARF2, ARF3, and ARF4 genes.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15980147","citation_count":223,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8917509","id":"PMC_8917509","title":"Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8917509","citation_count":131,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22296848","id":"PMC_22296848","title":"ETTIN (ARF3) physically interacts with KANADI proteins to form a functional complex essential for integument development and polarity determination in Arabidopsis.","date":"2012","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22296848","citation_count":122,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28552357","id":"PMC_28552357","title":"The THO Complex Non-Cell-Autonomously Represses Female Germline Specification through the TAS3-ARF3 Module.","date":"2017","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/28552357","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22971977","id":"PMC_22971977","title":"ARF1 and ARF3 are required for the integrity of recycling endosomes and the recycling pathway.","date":"2012","source":"Cell structure and function","url":"https://pubmed.ncbi.nlm.nih.gov/22971977","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8063710","id":"PMC_8063710","title":"Characterization of a glucose-repressible ADP-ribosylation factor 3 (ARF3) from Saccharomyces cerevisiae.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8063710","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20357002","id":"PMC_20357002","title":"Arf3 is activated uniquely at the trans-Golgi network by brefeldin A-inhibited guanine nucleotide exchange factors.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20357002","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33897748","id":"PMC_33897748","title":"Auxin Response Factor 2 (ARF2), ARF3, and ARF4 Mediate Both Lateral Root and Nitrogen Fixing Nodule Development in Medicago truncatula.","date":"2021","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/33897748","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35298645","id":"PMC_35298645","title":"Maize miR167-ARF3/30-polyamine oxidase 1 module-regulated H2O2 production confers resistance to maize chlorotic mottle virus.","date":"2022","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35298645","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23129621","id":"PMC_23129621","title":"Non-cell-autonomous regulation of crucifer self-incompatibility by Auxin Response Factor ARF3.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23129621","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26734029","id":"PMC_26734029","title":"MicroRNA390-Directed TAS3 Cleavage Leads to the Production of tasiRNA-ARF3/4 During Somatic Embryogenesis in Dimocarpus longan Lour.","date":"2015","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/26734029","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29415182","id":"PMC_29415182","title":"Arabidopsis Zinc-Finger-Like Protein ASYMMETRIC LEAVES2 (AS2) and Two Nucleolar Proteins Maintain Gene Body DNA Methylation in the Leaf Polarity Gene ETTIN (ARF3).","date":"2018","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29415182","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34346499","id":"PMC_34346499","title":"De novo ARF3 variants cause neurodevelopmental disorder with brain abnormality.","date":"2021","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34346499","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17425670","id":"PMC_17425670","title":"The Saccharomyces cerevisiae Arf3 protein is involved in actin cable and cortical patch formation.","date":"2007","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/17425670","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32415087","id":"PMC_32415087","title":"BIG1 controls macrophage pro-inflammatory responses through ARF3-mediated PI(4,5)P2 synthesis.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32415087","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26330566","id":"PMC_26330566","title":"Class I Arfs (Arf1 and Arf3) and Arf6 are localized to the Flemming body and play important roles in cytokinesis.","date":"2015","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26330566","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39659014","id":"PMC_39659014","title":"The long noncoding RNA ALEX1 confers a functional phase state of ARF3 to enhance rice resistance to bacterial pathogens.","date":"2024","source":"Molecular plant","url":"https://pubmed.ncbi.nlm.nih.gov/39659014","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36369169","id":"PMC_36369169","title":"Dominant ARF3 variants disrupt Golgi integrity and cause a neurodevelopmental disorder recapitulated in zebrafish.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36369169","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17786213","id":"PMC_17786213","title":"Identification of a guanine nucleotide exchange factor for Arf3, the yeast orthologue of mammalian Arf6.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17786213","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36880595","id":"PMC_36880595","title":"The small GTPase ARF3 controls invasion modality and metastasis by regulating N-cadherin levels.","date":"2023","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36880595","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32240746","id":"PMC_32240746","title":"circ_ARF3 regulates the pathogenesis of osteosarcoma by sponging miR-1299 to maintain CDK6 expression.","date":"2020","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/32240746","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11150519","id":"PMC_11150519","title":"Residues forming a hydrophobic pocket in ARF3 are determinants of GDP dissociation and effector interactions.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11150519","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33847108","id":"PMC_33847108","title":"ARF3 inhibits proliferation and promotes apoptosis in gastric cancer by regulating AKT and ERK pathway.","date":"2021","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/33847108","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34447403","id":"PMC_34447403","title":"Genome-Wide Identification of the ARF Gene Family and ARF3 Target Genes Regulating Ovary Initiation in Hazel via ChIP Sequencing.","date":"2021","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/34447403","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39120858","id":"PMC_39120858","title":"CircRNA Arf3 suppresses glomerular mesangial cell proliferation and fibrosis in diabetic nephropathy via miR-107-3p/Tmbim6 axis.","date":"2024","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/39120858","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41379936","id":"PMC_41379936","title":"ARF3-mediated auxin signaling is essential for sex determination in cucumber.","date":"2025","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/41379936","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37457110","id":"PMC_37457110","title":"A Novel Circ_Arf3/miR-452-5p/Mbnl1 Axis Regulates Proliferation and Expression of Fibrosis-Related Proteins of Mouse Mesangial Cells Under High Glucose.","date":"2023","source":"Diabetes, metabolic syndrome and obesity : targets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37457110","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38712921","id":"PMC_38712921","title":"Neurodevelopmental disorder associated with gene ARF3: A case report.","date":"2024","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/38712921","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41507605","id":"PMC_41507605","title":"Newly identified ARF3 variants strengthen the causal link between Golgi fragmentation and brain malformations.","date":"2026","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/41507605","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36920439","id":"PMC_36920439","title":"ARF3 weights the balance for prostate cancer metastasis.","date":"2023","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36920439","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39756487","id":"PMC_39756487","title":"ARF3 as a novel biomarker and target in acute myeloid leukemia: Insights from pan-cancer analysis.","date":"2025","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/39756487","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40608252","id":"PMC_40608252","title":"ARF3 knockdown inhibits influenza a virus and virus-induced pneumonia.","date":"2025","source":"Virus genes","url":"https://pubmed.ncbi.nlm.nih.gov/40608252","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41968069","id":"PMC_41968069","title":"The Arabidopsis ARF3-AIP1/2-SAP18 module specifies the root stem cell niche in response to auxin.","date":"2026","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/41968069","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41386637","id":"PMC_41386637","title":"The tasiR-ARF pathway in plants: origin, functions, and interplay of miR-390, tasiRNAs and ARF3.","date":"2025","source":"Plant biology (Stuttgart, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41386637","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.09.02.610784","title":"ETTIN-mediated auxin signalling is an angiosperm-specific neofunctionalization for carpel development","date":"2024-09-02","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.02.610784","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16713569","id":"PMC_16713569","title":"A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16713569","citation_count":610,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22119785","id":"PMC_22119785","title":"Defining human ERAD networks through an integrative mapping strategy.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22119785","citation_count":427,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20360068","id":"PMC_20360068","title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20360068","citation_count":421,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2105501","id":"PMC_2105501","title":"ADP-ribosylation factor is functionally and physically associated with the Golgi complex.","date":"1990","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2105501","citation_count":342,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23403292","id":"PMC_23403292","title":"Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23403292","citation_count":307,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35063084","id":"PMC_35063084","title":"Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.","date":"2022","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/35063084","citation_count":256,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10749927","id":"PMC_10749927","title":"A family of ADP-ribosylation factor effectors that can alter membrane transport through the trans-Golgi.","date":"2000","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/10749927","citation_count":232,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22678362","id":"PMC_22678362","title":"MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity.","date":"2012","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/22678362","citation_count":230,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20458337","id":"PMC_20458337","title":"MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.","date":"2010","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20458337","citation_count":221,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27705803","id":"PMC_27705803","title":"A High-Density Map for Navigating the Human Polycomb Complexome.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27705803","citation_count":216,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19135240","id":"PMC_19135240","title":"Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19135240","citation_count":208,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8355790","id":"PMC_8355790","title":"Coated vesicle assembly in the Golgi requires only coatomer and ARF proteins from the cytosol.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8355790","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32807901","id":"PMC_32807901","title":"UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32807901","citation_count":168,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22586326","id":"PMC_22586326","title":"Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.","date":"2012","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/22586326","citation_count":145,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19322201","id":"PMC_19322201","title":"Ubiquitin-mediated proteolysis of HuR by heat shock.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19322201","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23533145","id":"PMC_23533145","title":"In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.","date":"2013","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23533145","citation_count":138,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27926873","id":"PMC_27926873","title":"FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27926873","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29117863","id":"PMC_29117863","title":"RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.","date":"2017","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/29117863","citation_count":135,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23376485","id":"PMC_23376485","title":"Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.","date":"2013","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23376485","citation_count":126,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35140242","id":"PMC_35140242","title":"Human transcription factor protein interaction networks.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35140242","citation_count":123,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28718761","id":"PMC_28718761","title":"The human cytoplasmic dynein interactome reveals novel activators of motility.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28718761","citation_count":118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8491770","id":"PMC_8491770","title":"Two distinct populations of ARF bound to Golgi membranes.","date":"1993","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/8491770","citation_count":109,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":17731,"output_tokens":2891,"usd":0.048279},"stage2":{"model":"claude-opus-4-6","input_tokens":6197,"output_tokens":2977,"usd":0.158115},"total_usd":0.47204,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":29707,"output_tokens":4132,"usd":0.075551},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7796,"output_tokens":3510,"usd":0.190095}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"A brefeldin A-inhibited guanine nucleotide exchange protein (GEP) of ~200 kDa was purified from bovine brain cytosol and shown to catalyze GDP-to-GTP exchange on ARF1 and ARF3; the GEP contains a Sec7-like domain (47% identical to yeast Sec7), identifying it as a mammalian Sec7-family GEF for ARF3.\",\n      \"method\": \"Protein purification (DEAE-Sephacel, hydroxylapatite, Mono Q, Superose 6), SDS-PAGE silver staining, electroelution/renaturation activity assay, tryptic peptide sequencing\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution of GEF activity with direct peptide sequencing identifying Sec7 domain\",\n      \"pmids\": [\"8917509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Three residues of human ARF3 (F51, W66, Y81) form a hydrophobic pocket in the GDP-bound inactive conformation; mutagenesis of these residues increased rates of GDP dissociation and association, altered GTP binding kinetics, and selectively disrupted binding to different ARF effectors in two-hybrid assays, defining the pocket as a regulatory element for nucleotide exchange and effector coupling.\",\n      \"method\": \"Site-directed mutagenesis, in vitro nucleotide exchange assays, yeast two-hybrid effector binding assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis coupled with biochemical exchange assays and effector binding assays in a single study\",\n      \"pmids\": [\"11150519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mammalian Arf3 localizes selectively to the trans-Golgi network (TGN) rather than throughout the Golgi, in a manner that is temperature-sensitive and uniquely dependent on BIG-family (BFA-inhibited) guanine nucleotide exchange factors; BIG knockdown redistributes Arf3 but not Arf1 from Golgi membranes; mutagenesis identified pairs of residues at opposite ends of Arf3 that are required for TGN recruitment versus temperature-sensitive release, and these residues are absolutely conserved and unique to Arf3.\",\n      \"method\": \"Fluorescence microscopy, siRNA knockdown, temperature-shift experiments, site-directed mutagenesis, phylogenetic analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KD, mutagenesis, temperature-shift, localization imaging) in a single study with strong controls\",\n      \"pmids\": [\"20357002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ARF1 and ARF3 localize to endosomal compartments containing endocytosed transferrin, and simultaneous siRNA depletion of both ARF1 and ARF3 induces tubulation of recycling endosomes (positive for transferrin receptor, Rab4, and Rab11) and suppresses transferrin recycling to the plasma membrane without affecting Golgi integrity, early/late endosomes, retrograde TGN transport, or EGF degradation, establishing a redundant role for ARF1/ARF3 specifically in recycling endosome integrity and transferrin recycling.\",\n      \"method\": \"EGFP-tagging and fluorescence microscopy, siRNA double knockdown, transferrin recycling assay, TGN38 and CD4-furin retrograde transport assays\",\n      \"journal\": \"Cell structure and function\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double KD with multiple orthogonal trafficking readouts demonstrating pathway-specific requirement\",\n      \"pmids\": [\"22971977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Class I Arfs (Arf1 and Arf3) localize to the Flemming body during cytokinesis; double knockdown of Arf1 and Arf3 moderately increases multinucleate cells, and triple knockdown of Arf1, Arf3, and Arf6 causes severe cytokinesis defects, demonstrating redundant roles for these ARFs in completing cell division; EFA6 (exchange factor for Arf6) also activates Arf1 in the cell.\",\n      \"method\": \"Fluorescence microscopy localization, siRNA knockdown (double and triple), multinucleate cell quantification\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization and KD phenotype, but redundancy makes ARF3-specific contribution harder to isolate\",\n      \"pmids\": [\"26330566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BIG1 (a BFA-inhibited GEF) activates ARF3, which in turn promotes PI(4,5)P2 synthesis by activating PIP5K; this ARF3-dependent PI(4,5)P2 recruits TIRAP to the plasma membrane to support TLR4-MyD88 signaling in macrophages; BIG1 deficiency reduces ARF3 activation, PI(4,5)P2 levels, and pro-inflammatory cytokine production in LPS-stimulated macrophages and in sepsis mouse models.\",\n      \"method\": \"BIG1 conditional knockout mouse model, bone marrow-derived macrophage and THP-1 cell experiments, PI(4,5)P2 measurement, TIRAP membrane recruitment assay, LPS/CLP sepsis model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined biochemical pathway readouts, but ARF3's specific role inferred from BIG1 KO context\",\n      \"pmids\": [\"32415087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"De novo missense variants in human ARF3 (p.Asp67Val and p.Arg99Leu) cause neurodevelopmental disorder; p.Asp67Val shows dispersed cytosolic localization (similar to dominant-negative T31N) and loss-of-function in GGA1 binding (pull-down), while p.Arg99Leu localizes to Golgi and shows increased GGA1 binding (gain-of-function); in Drosophila, p.Asp67Val causes lethality and p.Arg99Leu causes abnormal rough eye similar to the known gain-of-function Q71L variant, establishing ARF3's role in Golgi-dependent neuronal development.\",\n      \"method\": \"Subcellular localization assays (fluorescence microscopy), pull-down assays for GGA1 binding, Drosophila in vivo expression studies\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (localization, pull-down, in vivo fly model) characterizing variant mechanism\",\n      \"pmids\": [\"34346499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"De novo missense ARF3 variants affecting residues in the guanine nucleotide binding pocket variably perturb protein stability and GTP/GDP binding; functional analysis shows variant-specific disruption of Golgi morphology, vesicle assembly, and trafficking; zebrafish modeling confirms dominant behavior and differential impact on brain size and body plan, with impaired neural precursor proliferation and planar cell polarity-dependent cell movements as earliest developmental effects.\",\n      \"method\": \"In vitro GTP/GDP binding assays, Golgi morphology assays, vesicle trafficking assays, zebrafish in vivo modeling, neural precursor proliferation analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical binding assays + cellular trafficking assays + in vivo zebrafish model with mechanistic readouts across multiple variants\",\n      \"pmids\": [\"36369169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARF3 controls the modality of collective cancer cell invasion by regulating N-cadherin levels; ARF3 associates with N-cadherin and controls its turnover; loss of ARF3 switches cells from leader cell-led chain invasion to collective sheet movement; in vivo, ARF3 levels act as a rheostat for metastasis from intraprostatic tumor transplants.\",\n      \"method\": \"3D functional genomic screen, co-association assays, N-cadherin turnover assays, in vivo intraprostatic transplant metastasis model\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional genomic screen + in vitro and in vivo mechanistic follow-up, though molecular detail of N-cadherin association is limited to a single lab\",\n      \"pmids\": [\"36880595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Novel ARF3 variants cause variant-specific effects on protein stability, GTP binding, and Golgi morphology; zebrafish models confirm dominant behavior and Golgi fragmentation in vivo; ARF3 mutants significantly affect brain size in zebrafish, recapitulating patient microcephaly, strengthening the link between ARF3-dependent Golgi integrity and nervous system development.\",\n      \"method\": \"Cell-based protein stability and GTP binding assays, Golgi morphology assays, zebrafish in vivo models\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — independent replication of ARF3 Golgi/brain phenotype across additional variants and zebrafish models\",\n      \"pmids\": [\"41507605\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human ARF3 is a small GTPase that cycles between GDP- and GTP-bound states at the trans-Golgi network (TGN), where it is selectively activated by BIG-family Sec7-domain GEFs in a BFA-sensitive manner; in its active (GTP-bound) form it recruits effectors such as GGA1 to regulate vesicle assembly and cargo sorting, maintains recycling endosome integrity to support transferrin recycling to the plasma membrane, promotes PI(4,5)P2 synthesis via PIP5K activation to facilitate TLR4-MyD88 inflammatory signaling, localizes to the Flemming body to support cytokinesis, and controls N-cadherin turnover to regulate collective cell invasion; disease-causing dominant missense variants disrupting the guanine nucleotide binding pocket fragment Golgi structure and impair neural precursor proliferation, causing a neurodevelopmental Golgipathy.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1990,\n      \"finding\": \"ARF protein is functionally and physically associated with the Golgi apparatus, localizing to the cytosolic surface of predominantly cis-Golgi membranes, and is required for intracellular protein transport to or within the Golgi apparatus, as demonstrated by phenotypic analysis of yeast arf1 null mutants (defective secretory pathway, partial glycosylation of invertase) and immunofluorescence/immunoelectron microscopy in mammalian cells.\",\n      \"method\": \"Yeast genetics (null mutation), immunofluorescence, immunoelectron microscopy\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal genetic and direct localization evidence, foundational study with 342 citations\",\n      \"pmids\": [\"2105501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"ARF proteins are the only cytoplasmic proteins required, together with coatomer, for the assembly and budding of COP-coated vesicles from Golgi membranes, demonstrating a direct role in coated vesicle formation.\",\n      \"method\": \"In vitro reconstitution of vesicle budding from Golgi membranes using purified cytosolic fractions\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution assay with purified components, highly cited foundational study\",\n      \"pmids\": [\"8355790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Two distinct populations of ARF exist on Golgi membranes: a liposome-sensitive pool that associates with the lipid bilayer upon GTP binding, and a saturable liposome-resistant pool that stably associates with a Golgi membrane protein component, suggesting ARF activation by a guanine nucleotide-exchange protein leads to myristoylated ARF-GTP membrane association followed by interaction with a target protein.\",\n      \"method\": \"Phosphatidylcholine liposome extraction of Golgi membranes, ARF binding assays with GTPγS\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with Golgi membranes and defined lipid competition, replicated across conditions\",\n      \"pmids\": [\"8491770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"A brefeldin A (BFA)-inhibited guanine nucleotide exchange protein (GEP) for ARF1 and ARF3 was purified from bovine brain cytosol; it is a ~200 kDa protein forming a ~670 kDa complex, and contains a Sec7-like domain (47% identity to yeast Sec7 over 51 amino acids), consistent with it being a mammalian Sec7 counterpart catalyzing ARF GDP-to-GTP exchange.\",\n      \"method\": \"Protein purification (DEAE-Sephacel, hydroxylapatite, Mono Q, Superose 6), SDS/PAGE, tryptic peptide sequencing, electroelution/renaturation activity assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical purification with activity reconstitution and peptide sequencing identification\",\n      \"pmids\": [\"8917509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Three residues of human ARF3 (F51, W66, Y81) form a hydrophobic pocket in the GDP-bound inactive state; mutations disrupting this pocket increased the rate of GDP dissociation and association without equivalently affecting GTPγS binding, and several mutants were selectively defective in binding different ARF effectors, establishing that this pocket regulates GDP release, conformational changes promoting GTP binding, and effector recognition.\",\n      \"method\": \"Site-directed mutagenesis of ARF3, GDP/GTP exchange rate assays, yeast two-hybrid effector binding assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with in vitro nucleotide exchange assays and effector binding tests\",\n      \"pmids\": [\"11150519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"A family of three ARF effector proteins (GGA1, GGA2, GGA3) were identified that interact preferentially with the GTP-bound (activated) form of ARF3; they localize to the trans-Golgi network (TGN) in an ARF- and BFA-sensitive manner, and overexpression alters distribution of TGN markers (TGN38, mannose 6-phosphate receptors), establishing GGAs as ARF3 effectors regulating membrane traffic through the TGN.\",\n      \"method\": \"Yeast two-hybrid screen with ARF3 as bait, recombinant protein binding assays, indirect immunofluorescence, BFA sensitivity assays, overexpression phenotypic analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — two-hybrid plus direct protein binding plus localization plus gain-of-function phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"10749927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In vivo, Arf3 (human class I ARF) localizes selectively to TGN membranes in a temperature-sensitive and BIG-family GEF-dependent manner distinct from Arf1; BIG1/BIG2 knockdown redistributes Arf3 but not Arf1 from Golgi membranes; shifting cells to 20°C selectively releases Arf3 from Golgi. Mutagenesis identified two pairs of residues at opposite ends of the protein responsible for TGN recruitment and temperature-dependent release. Phylogenetic analysis confirmed these four residues are absolutely conserved and unique to Arf3.\",\n      \"method\": \"siRNA knockdown, temperature-shift experiments, mutagenesis, fluorescence microscopy, phylogenetic analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KD, temperature shift, mutagenesis) in single rigorous study\",\n      \"pmids\": [\"20357002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Simultaneous depletion of ARF1 and ARF3 (but not either alone) induces tubulation of recycling endosomes positive for transferrin receptor, Rab4, and Rab11, and suppresses transferrin recycling from endosomes to the plasma membrane, without affecting Golgi integrity, early/late endosome function, or retrograde transport from endosomes to TGN. EGFP-tagged ARF1 and ARF3 localize to endosomal compartments containing endocytosed transferrin. ARF1 and ARF3 are thus redundantly required for recycling endosome integrity and transferrin recycling.\",\n      \"method\": \"siRNA double knockdown, EGFP localization, transferrin recycling assay, TGN38/CD4-furin retrograde transport assays, fluorescence microscopy\",\n      \"journal\": \"Cell structure and function\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double KO with multiple specific functional readouts and localization experiments\",\n      \"pmids\": [\"22971977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Class I Arfs (Arf1 and Arf3) localize to the Flemming body during cytokinesis; double knockdown of Arf1 and Arf3 moderately increases multinucleate cells, and triple knockdown of Arf1, Arf3, and Arf6 leads to severe cytokinesis defects. EFA6, an Arf6 exchange factor, also activates Arf1 in cells, suggesting EFA6 activates multiple Arfs locally at the Flemming body to complete cytokinesis.\",\n      \"method\": \"siRNA knockdown (single, double, triple), fluorescence localization to Flemming body, multinucleate cell quantification\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with specific cytokinesis phenotype, but Arf3-specific contribution partially confounded by redundancy with Arf1\",\n      \"pmids\": [\"26330566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BIG1 (a BFA-inhibited GEF) controls macrophage pro-inflammatory responses through ARF3 activation; myeloid-specific BIG1 knockout reduces ARF3 activation, leading to decreased PI(4,5)P2 synthesis, impaired TIRAP recruitment to the plasma membrane, and inhibition of TLR4-MyD88 signaling, thereby reducing TNF-α, IL-6, IL-1β, and IL-12 production in response to LPS.\",\n      \"method\": \"Myeloid-specific conditional knockout mice, LPS/CLP sepsis models, ARF3 activation assay, PI(4,5)P2 measurement, TIRAP membrane recruitment assay, cytokine quantification\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO with multiple downstream mechanistic readouts, but ARF3 activation shown indirectly downstream of BIG1 KO\",\n      \"pmids\": [\"32415087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"De novo missense variants in human ARF3 (p.Asp67Val and p.Arg99Leu) cause neurodevelopmental disorder with brain abnormalities. p.Asp67Val acts as a loss-of-function variant showing dispersed cytosolic/Golgi localization similar to the dominant-negative p.Thr31Asn, and decreased GGA1 binding. p.Arg99Leu localizes normally to Golgi but shows increased GGA1 binding (gain-of-function). In vivo, p.Asp67Val transfection caused lethality in Drosophila, while p.Arg99Leu caused abnormal rough eye (gain-of-function phenotype), demonstrating ARF3 is essential for Golgi transport and nervous system development.\",\n      \"method\": \"In vitro subcellular localization assays, pull-down assays for GGA1 binding, Drosophila in vivo expression of mutants\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (localization, pull-down, in vivo fly models) across two variants\",\n      \"pmids\": [\"34346499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"De novo missense ARF3 variants affecting the guanine nucleotide binding pocket variably perturb protein stability and GTP/GDP binding, with functional consequences including disrupted Golgi morphology and impaired vesicle assembly and trafficking. Zebrafish modeling confirmed dominant behavior of mutants, with differential impacts on brain size (impaired neural precursor proliferation) and body plan formation via planar cell polarity-dependent cell movements.\",\n      \"method\": \"Cell-based Golgi morphology assays, GTP/GDP binding assays, vesicle trafficking assays, zebrafish disease modeling, in vivo neural precursor proliferation analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal biochemical and in vivo methods across several variants, independently replicating and expanding prior findings\",\n      \"pmids\": [\"36369169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARF3 GTPase controls the modality of collective invasion in prostate cancer cells, acting as a switch between leader cell-led chain invasion and collective sheet movement; this function is dependent on ARF3's association with and control of N-cadherin turnover. In vivo, ARF3 levels acted as a rheostat for metastasis from intraprostatic tumor transplants.\",\n      \"method\": \"3D functional genomic screen, ARF3 KD/KO, N-cadherin co-immunoprecipitation and turnover assays, in vivo intraprostatic transplant metastasis model\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional screen plus mechanistic follow-up with binding partner and in vivo validation, single lab study\",\n      \"pmids\": [\"36880595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ARF3 knockdown inhibits influenza A virus (H3N2) replication in vitro and alleviates IAV-induced lung injury and pulmonary inflammation in vivo by attenuating NLRP3 inflammasome activation and reducing pro-inflammatory cytokines (TNF-α, IL-6, IL-1β).\",\n      \"method\": \"ARF3 knockdown in vitro (IAV replication assay), young mouse IAV pneumonia model, NLRP3 inflammasome activation assay, cytokine measurement\",\n      \"journal\": \"Virus genes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with specific viral replication and inflammasome phenotype, but single lab, mechanism between ARF3 and NLRP3 not fully dissected\",\n      \"pmids\": [\"40608252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ARF3 knockdown in AML cells interrupts cell cycle progression, promotes cell death, and inhibits leukemogenesis in vivo; mechanistically, ARF3 knockdown suppresses AML progression by inhibiting the PI3K/Akt signaling pathway.\",\n      \"method\": \"siRNA knockdown of ARF3 in AML cell lines, cell cycle and apoptosis assays, in vivo xenograft model, western blotting for PI3K/Akt pathway components\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with in vivo validation and pathway measurement, but single lab and PI3K/Akt link is correlational\",\n      \"pmids\": [\"39756487\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARF3 is a small GTPase that cycles between GDP-bound (inactive) and GTP-bound (active) states regulated by BFA-sensitive Sec7-domain GEFs (including BIG1/BIG2); in its active GTP-bound form it recruits effectors such as GGA proteins to the trans-Golgi network to drive coated vesicle assembly and cargo sorting, localizes selectively to the TGN (distinct from the broader Golgi distribution of ARF1) in a BIG-GEF-dependent manner, and together with ARF1 redundantly maintains recycling endosome integrity and transferrin recycling to the plasma membrane; de novo gain- or loss-of-function mutations in its guanine nucleotide-binding pocket cause Golgi fragmentation, impaired vesicle trafficking, and a human neurodevelopmental Golgipathy; additionally, ARF3 controls macrophage inflammatory signaling via PI(4,5)P2 synthesis downstream of BIG1, regulates collective cancer cell invasion modality through N-cadherin turnover, participates in cytokinesis at the Flemming body, and modulates NLRP3 inflammasome-dependent inflammatory responses during viral infection.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ARF3 is a class I small GTPase that cycles between GDP- and GTP-bound states to regulate vesicular trafficking, membrane identity, and cell signaling at the trans-Golgi network (TGN), recycling endosomes, and the plasma membrane. ARF3 is selectively recruited to the TGN by BIG-family Sec7-domain guanine nucleotide exchange factors in a brefeldin A-sensitive manner, where GTP-bound ARF3 engages effectors such as GGA1 to drive vesicle assembly and cargo sorting; a hydrophobic pocket formed by residues F51, W66, and Y81 governs nucleotide exchange kinetics and effector selectivity [PMID:8917509, PMID:11150519, PMID:20357002]. ARF3 acts redundantly with ARF1 to maintain recycling endosome tubular structure and transferrin recycling, localizes to the Flemming body during cytokinesis, promotes PI(4,5)P₂-dependent TLR4-MyD88 inflammatory signaling via PIP5K activation, and controls N-cadherin turnover to regulate collective cancer cell invasion modality [PMID:22971977, PMID:26330566, PMID:32415087, PMID:36880595]. Dominant de novo missense variants in the guanine nucleotide-binding pocket of ARF3 fragment Golgi structure, impair neural precursor proliferation, and cause a neurodevelopmental Golgipathy with microcephaly [PMID:34346499, PMID:36369169, PMID:41507605].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of the exchange factor machinery for ARF3 resolved how ARF3 is activated: a ~200 kDa BFA-inhibited GEP containing a Sec7-like domain catalyzes GDP-to-GTP exchange on ARF3, establishing that ARF3 activation depends on a Sec7-family GEF.\",\n      \"evidence\": \"Biochemical purification from bovine brain cytosol with reconstituted nucleotide exchange assay and tryptic peptide sequencing\",\n      \"pmids\": [\"8917509\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the specific BIG-family GEF isoform(s) preferentially acting on ARF3 in vivo was not resolved\", \"No structural basis for BFA sensitivity was provided\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defining the structural determinants of ARF3 nucleotide exchange and effector coupling revealed that a hydrophobic pocket (F51/W66/Y81) in the GDP-bound conformation acts as a regulatory switch controlling both exchange kinetics and selective effector engagement.\",\n      \"evidence\": \"Site-directed mutagenesis with in vitro nucleotide exchange assays and yeast two-hybrid effector binding\",\n      \"pmids\": [\"11150519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Effector selectivity was tested in yeast two-hybrid; direct binding affinities in purified systems were not measured\", \"Structural confirmation of the pocket conformation awaited crystallography\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing ARF3's distinctive subcellular address answered how ARF3 is functionally separated from its close paralog ARF1: ARF3 localizes selectively to the TGN via BIG-family GEF-dependent recruitment, with conserved ARF3-specific residues controlling both membrane association and temperature-sensitive release.\",\n      \"evidence\": \"Fluorescence microscopy, siRNA knockdown of BIG GEFs, temperature-shift experiments, and site-directed mutagenesis with phylogenetic analysis\",\n      \"pmids\": [\"20357002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical interaction between BIG GEFs and ARF3-specific residues was not demonstrated biochemically\", \"Functional consequences of TGN-selective localization for cargo sorting were not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating that ARF1 and ARF3 are jointly required for recycling endosome integrity and transferrin recycling — but dispensable for retrograde Golgi transport and EGF degradation — defined a pathway-specific post-Golgi function for class I ARFs.\",\n      \"evidence\": \"siRNA double knockdown in mammalian cells with transferrin recycling assays, endosome morphology imaging, and retrograde transport controls\",\n      \"pmids\": [\"22971977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ARF3-specific versus ARF1-specific contribution could not be separated due to redundancy\", \"Molecular mechanism by which ARF1/ARF3 maintain recycling endosome tubular structure was not identified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Localization of ARF3 to the Flemming body and cytokinesis failure upon triple ARF depletion extended ARF3 function beyond trafficking to cell division, though redundancy with ARF1 and ARF6 limited the ability to assign ARF3-specific contributions.\",\n      \"evidence\": \"Fluorescence microscopy localization and siRNA double/triple knockdown with multinucleate cell quantification\",\n      \"pmids\": [\"26330566\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ARF3-specific cytokinesis role could not be isolated from ARF1/ARF6 redundancy\", \"Downstream effectors at the Flemming body were not identified\", \"Mechanism linking ARF3 GTPase activity to abscission was not addressed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placing ARF3 in TLR4-MyD88 inflammatory signaling revealed a non-trafficking role: BIG1-activated ARF3 drives PI(4,5)P₂ synthesis via PIP5K at the plasma membrane, recruiting TIRAP to enable innate immune signaling in macrophages.\",\n      \"evidence\": \"BIG1 conditional knockout mouse, macrophage PI(4,5)P₂ quantification, TIRAP membrane recruitment, and LPS/CLP sepsis models\",\n      \"pmids\": [\"32415087\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ARF3's role was inferred from BIG1 knockout rather than direct ARF3 manipulation\", \"Whether ARF3 directly activates PIP5K or acts through an intermediate was not resolved\", \"Contribution of other BIG1 substrates was not excluded\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Discovery that de novo ARF3 missense variants (D67V, R99L) cause neurodevelopmental disorder through opposite biochemical mechanisms — loss-of-function versus gain-of-function in GGA1 effector binding and Golgi association — established ARF3 as a disease gene and linked its GTPase cycle to neural development.\",\n      \"evidence\": \"Subcellular localization, GGA1 pull-down assays, and Drosophila in vivo expression\",\n      \"pmids\": [\"34346499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Patient cohort was small; genotype-phenotype correlations were limited\", \"Mechanism by which altered GGA1 binding impairs neuronal development was not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Systematic biochemical and in vivo characterization of multiple ARF3 variants demonstrated that nucleotide-binding pocket mutations variably destabilize the protein and disrupt GTP/GDP binding, fragmenting Golgi structure and impairing neural precursor proliferation in zebrafish — defining the disease as a dominant Golgipathy.\",\n      \"evidence\": \"In vitro GTP/GDP binding assays, Golgi morphology analysis, zebrafish modeling with neural precursor proliferation readouts\",\n      \"pmids\": [\"36369169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for variant-specific effects on nucleotide binding was not resolved at atomic resolution\", \"Whether Golgi fragmentation is the primary cause or a correlate of impaired neural proliferation was not determined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of ARF3 as a regulator of N-cadherin turnover and collective invasion modality revealed a cell-biological axis through which ARF3 levels act as a rheostat controlling metastatic behavior in prostate cancer.\",\n      \"evidence\": \"3D functional genomic screen, N-cadherin co-association and turnover assays, intraprostatic transplant metastasis model\",\n      \"pmids\": [\"36880595\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of ARF3–N-cadherin association (direct binding vs. trafficking intermediate) was not resolved\", \"Generalizability beyond prostate cancer models was not tested\", \"Single-lab finding without independent replication\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Independent replication with additional ARF3 variants confirmed the genotype-phenotype spectrum and reinforced that Golgi fragmentation and brain-size reduction are consistent features of dominant ARF3 mutations, strengthening the causal link between ARF3-dependent Golgi integrity and nervous system development.\",\n      \"evidence\": \"Cell-based protein stability and GTP binding assays, Golgi morphology analysis, zebrafish brain-size models across novel variants\",\n      \"pmids\": [\"41507605\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No rescue experiments restoring wild-type ARF3 function were reported\", \"Downstream effector pathways mediating Golgi-to-brain phenotype remain uncharacterized\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular logic by which ARF3 GTPase cycling at the TGN is translated into specific developmental outcomes — particularly how Golgi fragmentation impairs neural precursor proliferation and whether planar cell polarity and N-cadherin regulation represent connected or parallel ARF3-dependent outputs — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of ARF3 in complex with BIG-family GEFs or GGA effectors\", \"Separation of ARF3-specific from ARF1-redundant functions in trafficking and cytokinesis is incomplete\", \"Pathway connecting ARF3-dependent Golgi integrity to neural precursor proliferation is undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [1, 6, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [2, 6, 7, 9]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 3, 7]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 7, 9]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 7, 9]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GGA1\",\n      \"ARF1\",\n      \"ARFGEF1\",\n      \"CDH2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"ARF3 is a class I ADP-ribosylation factor (small GTPase) that cycles between GDP-bound inactive and GTP-bound active states on endomembranes, functioning as a master regulator of vesicle coat assembly, cargo sorting, and membrane homeostasis at the trans-Golgi network, recycling endosomes, and the Flemming body during cytokinesis. In its GTP-bound form, ARF3 is recruited to TGN membranes in a BIG1/BIG2-dependent manner—distinct from the broader Golgi distribution of ARF1—where it engages effectors such as GGA1–3 to drive clathrin-coated vesicle formation and mannose 6-phosphate receptor trafficking [PMID:20357002, PMID:10749927]; together with ARF1 it redundantly maintains recycling endosome tubular architecture and transferrin recycling [PMID:22971977]. Beyond canonical trafficking, ARF3 controls macrophage TLR4 inflammatory signaling via BIG1-dependent PI(4,5)P₂ synthesis and TIRAP membrane recruitment [PMID:32415087], modulates NLRP3 inflammasome activation during influenza infection [PMID:40608252], and regulates collective cancer cell invasion through N-cadherin turnover [PMID:36880595]. De novo missense mutations in the ARF3 guanine-nucleotide-binding pocket cause a neurodevelopmental Golgipathy featuring brain malformations, with variants classified as gain- or loss-of-function based on effector binding and Golgi morphology effects validated in Drosophila and zebrafish models [PMID:34346499, PMID:36369169].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Establishing that ARF proteins localize to the Golgi apparatus and are required for secretory transport answered the fundamental question of where and why ARFs act in the cell.\",\n      \"evidence\": \"Yeast arf1 null mutant secretion defects combined with immunofluorescence and immunoelectron microscopy of mammalian Golgi membranes\",\n      \"pmids\": [\"2105501\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ARF isoform-specific functions not distinguished\", \"Mechanism of ARF membrane attachment unresolved\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Reconstitution of COP-coated vesicle budding from purified ARF and coatomer defined the minimal machinery for Golgi vesicle formation and showed ARF is an essential coat-assembly factor, while parallel work revealed two distinct modes of ARF-membrane association (lipid-dependent and protein-dependent).\",\n      \"evidence\": \"In vitro reconstitution of vesicle budding from Golgi membranes with purified components; liposome extraction and GTPγS-dependent ARF binding assays\",\n      \"pmids\": [\"8355790\", \"8491770\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the saturable Golgi membrane receptor for ARF unknown\", \"ARF3-specific contribution versus ARF1 not resolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Purification of a ~200 kDa BFA-sensitive guanine nucleotide exchange factor for ARF1/ARF3 containing a Sec7-like domain identified the upstream activator and explained how BFA blocks ARF-dependent vesicle trafficking.\",\n      \"evidence\": \"Biochemical purification from bovine brain cytosol with activity reconstitution and tryptic peptide sequencing\",\n      \"pmids\": [\"8917509\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity of this GEF not fully cloned at this stage\", \"Whether distinct GEFs preferentially activate ARF3 versus ARF1 unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mutagenesis of a hydrophobic pocket in ARF3 (F51/W66/Y81) established how conformational changes couple GDP release to effector recognition, while identification of GGA1–3 as GTP-dependent ARF3 effectors at the TGN defined the downstream pathway for clathrin-mediated sorting.\",\n      \"evidence\": \"Site-directed mutagenesis with nucleotide exchange and effector binding assays; yeast two-hybrid screen with ARF3-GTP, pull-down, and BFA-sensitive TGN localization of GGAs\",\n      \"pmids\": [\"11150519\", \"10749927\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of GGA–ARF3 interface not determined\", \"Whether all three GGAs are equally relevant in vivo unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that ARF3 localizes selectively to TGN membranes via BIG1/BIG2-dependent activation, distinct from the broader Golgi distribution of ARF1, resolved a long-standing question about isoform-specific compartmentalization and identified four conserved residues unique to ARF3 responsible for TGN targeting.\",\n      \"evidence\": \"siRNA knockdown of BIG1/BIG2, temperature-shift release experiments, and mutagenesis of ARF3-specific residues with fluorescence microscopy\",\n      \"pmids\": [\"20357002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of TGN receptor that recognizes ARF3-specific residues unknown\", \"Functional consequence of selective TGN targeting versus redundancy with ARF1 incompletely tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Double depletion of ARF1 and ARF3 revealed their redundant requirement for recycling endosome structural integrity and transferrin recycling, extending ARF3 function beyond the Golgi to endosomal compartments.\",\n      \"evidence\": \"siRNA double knockdown with transferrin recycling quantification, endosome tubulation assays, and EGFP-ARF localization to transferrin-positive endosomes\",\n      \"pmids\": [\"22971977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GEFs and effectors mediating ARF3 function specifically at recycling endosomes not identified\", \"Relative stoichiometric contributions of ARF1 versus ARF3 at endosomes unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Localization of ARF1/ARF3 to the Flemming body and cytokinesis defects upon their combined depletion extended ARF3 function to cell division, though ARF3's specific contribution is partially confounded by redundancy.\",\n      \"evidence\": \"siRNA single/double/triple knockdowns of Arf1, Arf3, and Arf6 with multinucleate cell quantification and Flemming body localization\",\n      \"pmids\": [\"26330566\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ARF3-specific role at the Flemming body not separable from ARF1\", \"Downstream effectors at the Flemming body not identified\", \"Single study without independent replication\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placing ARF3 downstream of BIG1 in macrophage TLR4 signaling—through PI(4,5)P₂ synthesis and TIRAP membrane recruitment—revealed an unexpected role for this trafficking GTPase in innate immune signal transduction.\",\n      \"evidence\": \"Myeloid-specific BIG1 conditional knockout mice with LPS/CLP sepsis models, ARF3 activation assays, PI(4,5)P₂ quantification, and TIRAP membrane recruitment\",\n      \"pmids\": [\"32415087\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ARF3 activation measured indirectly via BIG1 KO rather than direct ARF3 perturbation\", \"How ARF3-GTP activates PI(4,5)P₂ synthesis enzymes mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of de novo ARF3 missense mutations (p.Asp67Val, p.Arg99Leu) in patients with neurodevelopmental disorder established ARF3 as a human disease gene and demonstrated that gain- and loss-of-function variants in the nucleotide-binding pocket produce distinct cellular and in vivo phenotypes.\",\n      \"evidence\": \"Patient genotyping, subcellular localization, GGA1 pull-down assays, Drosophila in vivo expression of mutant ARF3\",\n      \"pmids\": [\"34346499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Neurodevelopmental mechanism downstream of impaired Golgi trafficking not delineated\", \"Limited patient cohort at initial report\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Expanded variant characterization in zebrafish confirmed dominant behavior of disease-associated ARF3 mutations and linked differential GTP/GDP binding perturbations to distinct effects on brain size and planar cell polarity, providing the first vertebrate disease model.\",\n      \"evidence\": \"Cell-based Golgi morphology and vesicle trafficking assays, GTP/GDP binding measurements, zebrafish disease modeling with neural precursor proliferation analysis\",\n      \"pmids\": [\"36369169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific cell types and developmental windows most sensitive to ARF3 dysfunction not defined\", \"Whether therapeutic correction of GTPase cycle is feasible untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A 3D functional genomic screen identified ARF3 as a controller of collective cancer invasion modality, acting through N-cadherin turnover to switch between chain and sheet migration, and revealed ARF3 levels modulate metastasis in vivo.\",\n      \"evidence\": \"3D screen, ARF3 KD/KO, N-cadherin co-immunoprecipitation and turnover, intraprostatic transplant metastasis model\",\n      \"pmids\": [\"36880595\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ARF3 directly binds N-cadherin or acts through an intermediary not resolved\", \"Generalizability beyond prostate cancer not tested\", \"Single lab study\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"ARF3 knockdown attenuated NLRP3 inflammasome activation during influenza infection in vitro and in vivo, positioning ARF3 as a positive regulator of inflammasome-dependent pulmonary inflammation; separately, ARF3 depletion in AML cells arrested cell cycle and inhibited leukemogenesis correlating with PI3K/Akt pathway suppression.\",\n      \"evidence\": \"ARF3 KD with IAV replication and NLRP3 activation assays in mouse pneumonia model; ARF3 KD in AML cell lines with xenograft model and PI3K/Akt western blotting\",\n      \"pmids\": [\"40608252\", \"39756487\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic link between ARF3 GTPase activity and NLRP3 assembly not dissected\", \"PI3K/Akt connection in AML is correlational—direct substrate or adaptor unknown\", \"Neither finding independently replicated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the identity of the TGN membrane receptor that selectively recognizes ARF3 over ARF1, the structural basis for effector selectivity among ARF3 disease variants, the precise mechanism by which ARF3-GTP activates PI(4,5)P₂ synthesis, and whether therapeutic modulation of the ARF3 GTPase cycle could rescue the associated Golgipathy.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of ARF3–effector complexes available\", \"TGN-specific ARF3 receptor not molecularly identified\", \"No therapeutic intervention studies\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [3, 4, 10, 11]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 9, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 2, 6, 10, 11]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [1, 7]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 10]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 5, 6, 7, 10, 11]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [5, 6, 7]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9, 13]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 14]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [8, 14]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [10, 11]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GGA1\",\n      \"GGA2\",\n      \"GGA3\",\n      \"BIG1\",\n      \"BIG2\",\n      \"ARF1\",\n      \"CDH2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}